BEWARE OF FRAUDULENT SCHEMES CLAIMING TO REPRESENT PT VERDHANA SEKURITAS INDONESIA

• Please be cautious of any fraudulent schemes conducted by parties claiming to represent PT Verdhana Sekuritas Indonesia. These scams often use the name, logo, and identity of PT Verdhana Sekuritas Indonesia to pose as official company representatives.
  
• Identified scam methods include investment fraud, job offers, task assignments, or other programs that appear to offer monetary rewards or commissions. Please remain vigilant against other forms of fraud as well.
  
• These scams may be carried out through various media channels, including:
  1. Fake websites;
  2. Messaging apps such as WhatsApp, Telegram, SMS, etc.;
  3. Fake emails and letters;
  4. Fraudulent phone calls. 
• PT Verdhana Sekuritas Indonesia operates solely as a Securities Broker-Dealer and Underwriter. We are not an investment manager or an institution that offers investment programs, job offers, commission-based tasks, or other financial schemes directly to the public via social media, private messages, phone calls, or unofficial individual agents. We do not appoint any individual or third party to collect funds from the public. 
• We never request the public, prospective clients, or our clients to (1) conduct cash transactions or (2) transfer funds to any personal account of individuals claiming to be employees or representatives of PT Verdhana Sekuritas Indonesia.
  
• Official information from PT Verdhana Sekuritas Indonesia is communicated only through our official channels:
  Website: www.verdhana.id and www.verdhanaresearch.com 
  Email: info@verdhana.id
  Phone: (021) 5098 5799
  Address: Deutsche Bank Building, 18th Floor, Jl. Imam Bonjol No. 80, Jakarta 10310 
• If you receive any suspicious messages, offers, or solicitations conducted by parties claiming to represent PT Verdhana Sekuritas Indonesia, please do not respond and report them immediately to us via email at info@verdhana.id.

This announcement is hereby conveyed. Thank you for your attention and for placing your trust in PT Verdhana Sekuritas Indonesia.
Sincerely,

PT Verdhana Sekuritas Indonesia

 CLOSE 

Home   /   Latest Research

Default sorting Sort by Popularity Sort by Average rating Sort by Featured

• Indonesia Banks - YTD May-25 results summary

  EW

  Indonesia major banks (BBCA IJ, BMRI IJ, BRIS IJ, BBNI IJ and BBRI IJ...

  BANKS Erwin Wijaya

  1 month ago

• Bank Mandiri (BMRI IJ) (Buy) - YTD May-25 earnings flat

  EW

  We recently lowered our FY25F-27F earnings...

  BANKS BMRI BMRI JK BMRI IJ Erwin Wijaya

  2 months ago

• Bank Mandiri (BMRI IJ) (Buy) - Decent Apr-25 results boosted by lower CoC

  EW

  BMRI released its bank-only Apr-25 results...

  BANKS BMRI BMRI JK BMRI IJ Erwin Wijaya

  3 months ago

• Bank Mandiri (BMRI IJ) (Buy) - 1Q25: A decent start

  EW

  BMRI posted consolidated 1Q25 results...

  BANKS BMRI BMRI JK BMRI IJ Erwin Wijaya

  3 months ago

• Bank Mandiri (BMRI IJ) (Buy) - Feb-25: Satisfactory results due to declined provisioning

  EW

  BMRI has released its bank-only Feb-25 results.

  BANKS BMRI BMRI JK BMRI IJ Erwin Wijaya

  5 months ago

• Bank Mandiri (BMRI IJ) (Buy) - Jan-25 Results

  EW

  BMRI started 2025 with satisfactory bank-only Jan-25 results—

  BANKS BMRI BMRI JK BMRI IJ Erwin Wijaya

  6 months ago

• Bank Mandiri (BMRI IJ) (Buy) - Earnings update, TP adjustment

  EW

  Post FY24 results, we revise our FY25-26F earnings estimates.

  Banks BMRI BMRI JK BMRI IJ Erwin Wijaya

  6 months ago

• Bank Mandiri (BMRI IJ) (Buy) - Unexciting (in-line) FY24 results

  EW

  BMRI has released its FY24 results with headline consolidated profit at IDR55.8tn (+1.3% y-y).

  Banks BMRI BMRI JK BMRI IJ Erwin Wijaya

  6 months ago

• Bank Mandiri (BMRI IJ) (Buy) - 9M24 – Steady growth

  NS EW

  BMRI released its 9M24 results on 30 October, with the company remaining on a steady growth trajectory.

  Banks BMRI BMRI JK BMRI IJ Nicholas Santoso Erwin Wijaya

  9 months ago

• Bank Mandiri (BMRI IJ) (Buy) - Lower risks to growth

  NS EW

  We took a closer look at BMRI’s provisioning expenses (12MMA CoC) which has stabilised at ~70-80bp in 1H24.

  Banks BMRI BMRI JK BMRI IJ Nicholas Santoso Erwin Wijaya

  10 months ago

• Bank Mandiri -BMRI IJ- Buy - Jul-24 results in line with forecast

  NS EW

  BMRI released its bank-only Jul-24 results with monthly earnings

  Banks BMRI JK BMRI IJ Nicholas Santoso Erwin Wijaya

  1 year ago

• Bank Mandiri -BMRI IJ- Buy - Better stability in ROE ROA Re-rating to continue

  NS EW

  These improvements were largely driven by the bank’s increased

  Banks BMRI JK BMRI IJ Nicholas Santoso Erwin Wijaya

  1 year ago